Analyst Consensus ?
ConsensusBuy46 ratings
Bullish2554.3%
Neutral2043.5%
Bearish12.2%
FN2 Earnings Intelligence
Constellation Brands, Inc. analyst ratings
Constellation Brands, Inc. (STZ) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$130.38Current
$132Low
$231.93Average
$335High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 21, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 2, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 2, 2026 |
| Needham | Buy | Buy | Maintain | Jul 2, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 2, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 2, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Jul 2, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 2, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 2, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 1, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 29, 2026 |
| Jefferies | Hold | Hold | Maintain | Jun 24, 2026 |
| UBS | Buy | Buy | Maintain | Jun 17, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Apr 13, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 10, 2026 |
| Citigroup | Buy | Neutral | Upgrade | Mar 18, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 2, 2025 |
| Roth MKM | Buy | Buy | Maintain | Apr 3, 2025 |
| Truist Securities | Hold | Hold | Maintain | Jan 14, 2025 |
| Argus Research | Buy | Hold | Upgrade | Apr 15, 2024 |
| HSBC | Buy | Buy | Maintain | Apr 12, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Apr 10, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jan 6, 2023 |
| Cowen & Co. | Market Perform | Outperform | Downgrade | Jan 6, 2023 |
| Redburn Partners | Buy | Buy | Maintain | Jul 13, 2022 |
| MKM Partners | Neutral | Neutral | Maintain | Jul 1, 2021 |
| OTR Global | Mixed | Positive | Downgrade | Jun 18, 2021 |
| Wolfe Research | Outperform | Outperform | Maintain | Apr 13, 2021 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Oct 14, 2020 |
| Guggenheim | Neutral | Neutral | Maintain | Jun 25, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 3, 2020 |
| SunTrust Robinson Humphrey | Hold | Hold | Maintain | Jul 1, 2019 |
| Susquehanna | Neutral | Negative | Upgrade | Jan 7, 2019 |
| Macquarie | Neutral | Neutral | Maintain | Dec 17, 2018 |
| Bank of America | Buy | Buy | Maintain | Oct 5, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 2, 2018 |
| Stifel | Hold | Hold | Maintain | Jul 2, 2018 |
| Nomura | Neutral | Neutral | Maintain | Sep 17, 2015 |
| CLSA | Outperform | Outperform | Maintain | Sep 1, 2015 |
| Societe Generale | Hold | Sell | Upgrade | Jan 13, 2015 |
| Pivotal Research | Buy | Buy | Maintain | Oct 20, 2014 |
| DA Davidson | Buy | Buy | Maintain | Jan 8, 2014 |
| ISI Group | Strong Buy | Buy | Upgrade | May 16, 2013 |
| Buckingham Research | Buy | Buy | Maintain | Jan 16, 2013 |
| Bank oferica | Buy | Buy | Maintain | Mar 22, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $130.38. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $132 | $134.36 | +1.2% | Jul 21, 2026 |
| Deutsche Bank | Steve Powers | $150 | $138.34 | +15.0% | Jul 2, 2026 |
| Morgan Stanley | Dara Mohsenian | $158 | $136.88 | +21.2% | Jul 2, 2026 |
| Barclays | Analyst unavailable | $139 | $136.88 | +6.6% | Jul 2, 2026 |
| Jefferies | Analyst unavailable | $147 | $136.88 | +12.7% | Jul 2, 2026 |
| BMO Capital | Analyst unavailable | $174 | $137.49 | +33.5% | Jul 1, 2026 |
| Jefferies | Analyst unavailable | $157 | $143.36 | +20.4% | Jun 23, 2026 |
| Evercore ISI | Analyst unavailable | $175 | $167.96 | +34.2% | Apr 10, 2026 |
| Barclays | Analyst unavailable | $170 | $167.96 | +30.4% | Apr 10, 2026 |
| Deutsche Bank | Analyst unavailable | $155 | $167.96 | +18.9% | Apr 10, 2026 |
| Needham | Gerald Pascarelli | $185 | $167.96 | +41.9% | Apr 10, 2026 |
| UBS | Analyst unavailable | $186 | $167.96 | +42.7% | Apr 10, 2026 |
| Piper Sandler | Analyst unavailable | $160 | $167.96 | +22.7% | Apr 10, 2026 |
| Wells Fargo | Chris Carey | $185 | $167.96 | +41.9% | Apr 10, 2026 |
| Barclays | Analyst unavailable | $148 | $147 | +13.5% | Jan 12, 2026 |
| BMO Capital | Andrew Strelzik | $190 | $147.51 | +45.7% | Jan 9, 2026 |
| UBS | Peter Grom | $168 | $147.89 | +28.9% | Jan 9, 2026 |
| Bernstein | Analyst unavailable | $197 | $147.96 | +51.1% | Jan 9, 2026 |
| Wells Fargo | Analyst unavailable | $165 | $140.49 | +26.6% | Jan 8, 2026 |
| Wells Fargo | Bonnie Herzog | $160 | $141.17 | +22.7% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $154 | $142.59 | +18.1% | Dec 16, 2025 |
| Deutsche Bank | Analyst unavailable | $160 | $142.02 | +22.7% | Dec 15, 2025 |
| Piper Sandler | Michael Lavery | $135 | $130.45 | +3.5% | Nov 21, 2025 |
| Barclays | Analyst unavailable | $147 | $142.76 | +12.7% | Oct 9, 2025 |
| Needham | Gerald Pascarelli | $180 | $140.14 | +38.1% | Oct 8, 2025 |
| UBS | Analyst unavailable | $160 | $138.71 | +22.7% | Oct 7, 2025 |
| UBS | Analyst unavailable | $175 | $140.51 | +34.2% | Oct 3, 2025 |
| Bernstein | Analyst unavailable | $195 | $145.88 | +49.6% | Sep 4, 2025 |
| Roth Capital | William Kirk | $209 | $147.28 | +60.3% | Sep 3, 2025 |
| Wells Fargo | Chris Carey | $170 | $146.49 | +30.4% | Sep 3, 2025 |
| Goldman Sachs | Analyst unavailable | $196 | $151.26 | +50.3% | Sep 2, 2025 |
| Goldman Sachs | Boonie Herzog | $225 | $161.32 | +72.6% | Jun 27, 2025 |
| Barclays | Lauren Lieberman | $202 | $161.53 | +54.9% | Jun 26, 2025 |
| UBS | Peter Grom | $195 | $161.53 | +49.6% | Jun 25, 2025 |
| Truist Financial | Bill Chappell | $215 | $187.07 | +64.9% | May 7, 2025 |
| Barclays | Analyst unavailable | $205 | $181.59 | +57.2% | Mar 13, 2025 |
| RBC Capital | Analyst unavailable | $289 | $186.25 | +121.7% | Mar 7, 2025 |
| Morgan Stanley | Dara Mohsenian | $202 | $178.35 | +54.9% | Feb 27, 2025 |
| BMO Capital | Andrew Strelzik | $305 | $245.71 | +133.9% | Oct 15, 2024 |
| Barclays | Lauren Lieberman | $300 | $246.67 | +130.1% | Oct 4, 2024 |
| HSBC | Sorabh Daga | $285 | $246.67 | +118.6% | Oct 4, 2024 |
| Roth Capital | William Kirk | $298 | $246.36 | +128.6% | Oct 4, 2024 |
| Evercore ISI | Robert Ottenstein | $300 | $246 | +130.1% | Oct 4, 2024 |
| Truist Financial | Bill Chappell | $255 | $243.65 | +95.6% | Oct 4, 2024 |
| Jefferies | Kaumil Gajrawala | $309 | $246.67 | +137.0% | Oct 4, 2024 |
| J.P. Morgan | Andrea Teixeira | $307 | $255.67 | +135.5% | Oct 3, 2024 |
| Deutsche Bank | Steve Powers | $256 | $246.78 | +96.3% | Sep 3, 2024 |
| Citigroup | Filippo Falorni | $305 | $246.78 | +133.9% | Sep 3, 2024 |
| Morgan Stanley | Dara Mohsenian | $280 | $244.5 | +114.8% | Aug 26, 2024 |
| Barclays | Lauren Lieberman | $295 | $248.26 | +126.3% | Jul 19, 2024 |
| Wells Fargo | Bonnie Herzog | $300 | $259.14 | +130.1% | Jul 5, 2024 |
| CFRA | Garrett Nelson | $335 | $250.37 | +156.9% | Jul 3, 2024 |
| Barclays | Lauren Lieberman | $288 | $245.49 | +120.9% | May 28, 2024 |
| Jefferies | Kaumil Gajrawala | $311 | $258.77 | +138.5% | May 14, 2024 |
| Argus Research | John Staszak | $306 | $262.24 | +134.7% | Apr 15, 2024 |
| Truist Financial | Bill Chappell | $265 | $262.24 | +103.3% | Apr 15, 2024 |
| RBC Capital | Nik Modi | $308 | $268.34 | +136.2% | Apr 12, 2024 |
| Jefferies | Kaumil Gajrawala | $314 | $268.34 | +140.8% | Apr 12, 2024 |
| BMO Capital | Andrew Strelzik | $315 | $268.34 | +141.6% | Apr 12, 2024 |
| Deutsche Bank | Steve Powers | $264 | $268.34 | +102.5% | Apr 12, 2024 |
| Goldman Sachs | Bonnie Herzog | $300 | $268.34 | +130.1% | Apr 12, 2024 |
| Evercore ISI | Robert Ottenstein | $310 | $268.34 | +137.8% | Apr 12, 2024 |
| CFRA | Garrett Nelson | $270 | $267.4 | +107.1% | Apr 11, 2024 |
| Wells Fargo | Chris Carey | $295 | $266 | +126.3% | Apr 9, 2024 |
| RBC Capital | Nik Modi | $295 | $264.31 | +126.3% | Apr 5, 2024 |
| Deutsche Bank | Steve Powers | $262 | $268.14 | +101.0% | Apr 2, 2024 |
| Piper Sandler | Michael Lavery | $300 | $269.35 | +130.1% | Mar 21, 2024 |
| Roth Capital | William Kirk | $311 | $238.7 | +138.5% | Oct 6, 2023 |
| Goldman Sachs | Bonnie Herzog | $305 | $249.36 | +133.9% | Oct 5, 2023 |
| Wedbush | Gerald Pascarelli | $300 | $248.33 | +130.1% | Oct 3, 2023 |
| Morgan Stanley | Dara Mohsenian | $290 | $246.85 | +122.4% | Jun 30, 2023 |
| Evercore ISI | Analyst unavailable | $260 | $231.52 | +99.4% | Jan 31, 2023 |
| J.P. Morgan | Analyst unavailable | $250 | $214.23 | +91.7% | Jan 6, 2023 |
| Morgan Stanley | Analyst unavailable | $277 | $215 | +112.5% | Jan 6, 2023 |
| UBS | Analyst unavailable | $267 | $212.89 | +104.8% | Jan 6, 2023 |
| BMO Capital | Analyst unavailable | $265 | $208.68 | +103.3% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $250 | $208.68 | +91.7% | Jan 6, 2023 |
| Cowen & Co. | Analyst unavailable | $200 | $208.68 | +53.4% | Jan 6, 2023 |
| Wells Fargo | Analyst unavailable | $270 | $227.79 | +107.1% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $245 | $232.77 | +87.9% | Dec 21, 2022 |
| Deutsche Bank | Analyst unavailable | $249 | $247.38 | +91.0% | Dec 6, 2022 |
| Barclays | Lauren Lieberman | $281 | $235.43 | +115.5% | Jul 5, 2022 |
| UBS | Analyst unavailable | $270 | $230.03 | +107.1% | Jun 21, 2022 |
| Jefferies | Kevin Grundy | $305 | $230.03 | +133.9% | Jun 14, 2022 |
| Goldman Sachs | Bonnie Herzog | $275 | $230.34 | +110.9% | Apr 5, 2022 |
| Morgan Stanley | Dara Mohsenian | $294 | $229.71 | +125.5% | Apr 4, 2022 |
| Jefferies | Kevin Grundy | $310 | $229.71 | +137.8% | Apr 4, 2022 |
| Barclays | Lauren Lieberman | $278 | $233.71 | +113.2% | Apr 1, 2022 |
| Wells Fargo | Christopher Carey | $275 | $225.85 | +110.9% | Mar 21, 2022 |
| Barclays | Lauren Lieberman | $277 | $248.64 | +112.5% | Jan 15, 2022 |
| Argus Research | John Staszak | $290 | $245.39 | +122.4% | Jan 7, 2022 |
| UBS | Sean King | $285 | $245.39 | +118.6% | Jan 7, 2022 |
| Citigroup | Wendy Nicholson | $265 | $245.39 | +103.3% | Jan 7, 2022 |
| Guggenheim | Laurent Grandet | $242 | $244.01 | +85.6% | Jan 6, 2022 |
| Cowen & Co. | Vivien Azer | $275 | $233.93 | +110.9% | Dec 8, 2021 |
| HSBC | Carlos Laboy | $262 | $217.68 | +101.0% | Oct 13, 2021 |
| Bernstein | Trevor Stirling | $305 | $234.1 | +133.9% | May 24, 2021 |
| Wolfe Research | Greg Badishkanian | $265 | $223.32 | +103.3% | Apr 12, 2021 |
Track every rating change on STZ the moment it posts. Free to start.
Start free